Home Latest Deals BMS Laboratories

Indian drug maker Dr Reddy’s has made its first overseas acquisition in a deal to buy two small British generic drug companies for £9m ($12.7m).
Dr Reddy’s, India’s only US-listed pharmaceutical company, said the acquisition of BMS Laboratories and its subsidiary Meridian Healthcare would be completed by early April.

Chief executive G V Prasad said the acquisition would “jumpstart” the company’s generics business in the UK.

“This acquisition gives an entry for Dr Reddy into Europe, which it’s been looking for for some time,” Rusmik Oza, Mumbai-based brokerage Karvy Stock Broking told the BBC’s World Business Report.

“It will be the platform for Dr Reddy to first increase sales in the UK and then in Europe.”

British generics

The Hyderabad-based drug maker said the BMS group made solid and liquid medication and packaging.

In a statement it said Meridian currently sold 30 generic products and planned to get licences for another 70.

The BMS group made a profit of £1.6m on sales of £8million in 2001.

US market

Dr Reddy’s main export market for its generic drugs is the US.

It has sold $60m worth of a generic copy of Eli Lilly’s anti-depressant Prozac in the US.

Other Indian drug makers like Ranbaxy Laboratories, Wockhardt and Sun Pharmaceutical Industries have already made acquisitions in the US and Europe.

on the sale to

Sector Healthcare
Deal Type Sale
Value £9m

Contact Us

Recent Deals

Fanatical on the sale to Fandom

  • Sale
  • Software
  • Tech

Bowman Stores on the sale to Americold

  • Sale
  • Business Services
  • Industrial

Virtual Recall on the sale to Zoetis

  • Sale
  • Software
  • Tech

Davies Veterinary Specialists on the sale to Mars Petcare

  • Sale
  • Healthcare

My School Portal on the sale to The Access Group

  • Sale
  • Education
  • Software
  • Tech

Enva on the acquisition of Associated Reclaimed Oils

  • Acquisition
  • Business Services
  • Industrial
View all Transactions

Bishopsgate CF Advisors

Simon Stephenson

Partner
Tel:
Tel: 00 44 (0)1780 756544
Email:
Contact Simon

Other deals that may interest you

on the sale to

Sale n/d
Deal Information
on the sale to

Sale £74m
Deal Information
on the sale to

Sale n/d
Deal Information
on the sale to

Sale n/d
Deal Information
on the sale to

Sale n/d
Deal Information
on the acquisition of

Acquisition n/d
Deal Information
Private Equity

Private Equity n/d
Deal Information
on the sale to

Sale n/d
Deal Information
Bishopsgate Logo

Midlands Office

King’s Mill Centre
St Peter’s Vale
Stamford
PE9 2QT

+44 1780 756 544

London Office

99 Bishopsgate
London
EC2M 3XD

+44 20 36937261

Loading